{"name":"Amir Moradi MD, MBA","slug":"amir-moradi-md-mba","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"OnabotulinumtoxinA 50 UNT [Botox Cosmetic]","genericName":"OnabotulinumtoxinA 50 UNT [Botox Cosmetic]","slug":"onabotulinumtoxina-50-unt-botox-cosmetic","indication":"Temporary improvement of moderate to severe glabellar lines (frown lines) in adults","status":"marketed"}]}],"pipeline":[{"name":"OnabotulinumtoxinA 50 UNT [Botox Cosmetic]","genericName":"OnabotulinumtoxinA 50 UNT [Botox Cosmetic]","slug":"onabotulinumtoxina-50-unt-botox-cosmetic","phase":"marketed","mechanism":"OnabotulinumtoxinA blocks acetylcholine release at the neuromuscular junction, paralyzing muscles and reducing dynamic wrinkles.","indications":["Temporary improvement of moderate to severe glabellar lines (frown lines) in adults","Temporary improvement of moderate to severe lateral canthal lines (crow's feet) in adults","Temporary improvement of moderate to severe forehead lines in adults"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxNdUN2MThaaV9KUzFwYkFPUm9tQ1pwT04zenVXZ1BUdnZ3ZTF3NTNrY3lYcW9abWhTQ0syd1RLT2tnbndodUlQZzJwV0x5RF91U0pRVkRuaWVYOVhqWE14dVA0S0s4RDY5RmhmQXRTY3d4RTFFdGctWVZoaTBydFBBWGE5Q01yYWlkSV9lN3JuTVBGWEYzYkhadHZadklNVUlkdFlXRHBlV2VlUUhmUmxhUUZ1ZEpmUnlCb01nNWFMUEE0UThKMnBhRHNEMVFVNV9KRzkzZTFfY3JiU0wzOEdHREZRX0FaX085ZXZxODVHaS1RR0g0bTFveGFHcWV2aDk5RXVvUWJzYlZ6ck84dUpYUkE4QXc2b0x2Mk1Nd1Rlb3pVOFlT?oc=5","date":"2024-12-12","type":"pipeline","source":"PR Newswire","summary":"Clinical Validation Of Ourself Delivery Technology Published In Dermatologic Surgery: Tiered-Release Vesicles™ Poised To Revolutionize Skincare - PR Newswire","headline":"Clinical Validation Of Ourself Delivery Technology Published In Dermatologic Surgery: Tiered-Release Vesicles™ Poised To","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}